Edition:
United Kingdom

Aquestive Therapeutics Q4 Loss Per Share $0.56


Thursday, 14 Mar 2019 

March 14 (Reuters) - Aquestive Therapeutics Inc ::AQUESTIVE THERAPEUTICS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS.Q4 REVENUE $16.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF $16.7 MILLION.Q4 LOSS PER SHARE $0.56.Q4 EARNINGS PER SHARE ESTIMATE $-0.51 -- REFINITIV IBES DATA.SEES FULL YEAR 2019 TOTAL REVENUES OF $33 MILLION TO $45 MILLION.SEES FULL YEAR 2019 NON-GAAP ADJUSTED EBITDA LOSS OF $40 MILLION TO $45 MILLION.SEES FULL YEAR 2019 CASH BURN OF APPROXIMATELY $45 MILLION TO $50 MILLION. 

Latest Developments forAquestive Therapeutics Inc

Company Quote

4.23
-0.28 -6.21%
24 May 2019